SEC Filing Details
Document Details
Form
Filing Date
Feb 6, 2022
Document Date
Feb 2, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.
Filer
Harris Erik